Cervical carcinoma (CC) represents the predominant malignancy affecting the female population, with patient outcomes being a critical focus of clinical investigation. This research conducts a comprehensive evaluation of the clinical determinants influencing short-term survival rates in CC patients receiving definitive radiotherapy treatment. A total of 99 cervical cancer patients who received radical radiotherapy between April 2017 and March 2022 at two medical institutions were retrospectively examined. Clinical outcomes were evaluated using the Kaplan-Meier method and the Cox proportional hazards model. A total of ninety - nine patients with cervical cancer who received radical radiotherapy were included in the study. The overall survival (OS) rate at 2 - year follow - up was 77.8%.COX unifactorial and multifactorial showed that the analysis of prognostic-related factors suggested that the higher the history of miscarriage and FIGO stage, the lower 2-year OS, and that the history of miscarriage and FIGO stage were independent factors affecting the short-term overall survival, and the difference of all of them was statistically significant (P < 0.05). A history of miscarriage and the FIGO classification stage serve as independent predictors of overall survival (OS) during the initial 24-month period for cervical carcinoma patients undergoing definitive radiotherapy. This study conducted a comprehensive analysis of short-term prognostic indicators for cervical squamous cell carcinoma patients undergoing radical chemoradiotherapy.
Hao et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: